X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (113) 113
female (57) 57
oncology (55) 55
cancer (48) 48
middle aged (41) 41
male (40) 40
immunotherapy (38) 38
melanoma (37) 37
aged (35) 35
pathology (34) 34
adult (32) 32
immunohistochemistry (32) 32
tumors (30) 30
pd-l1 (27) 27
pd-1 (22) 22
aged, 80 and over (20) 20
biomarkers (20) 20
surgery (20) 20
care and treatment (19) 19
lymphocytes (19) 19
immunology (18) 18
animals (17) 17
skin neoplasms - pathology (17) 17
lymphocytes t (16) 16
lymphocytes, tumor-infiltrating - immunology (16) 16
patients (16) 16
programmed cell death 1 receptor - antagonists & inhibitors (16) 16
blockade (15) 15
pd-1 protein (15) 15
safety (15) 15
survival (15) 15
abridged index medicus (14) 14
b7-h1 antigen - metabolism (14) 14
expression (14) 14
immune checkpoint (14) 14
melanoma - pathology (14) 14
b7-h1 antigen - immunology (13) 13
carcinoma (13) 13
dermatology (13) 13
metastasis (13) 13
pd-l1 protein (13) 13
analysis (12) 12
cancer therapies (12) 12
diagnosis (12) 12
metastatic melanoma (12) 12
nivolumab (12) 12
research (12) 12
apoptosis (11) 11
b7-h1 (11) 11
b7-h1 antigen - antagonists & inhibitors (11) 11
biomarkers, tumor - metabolism (11) 11
health aspects (11) 11
ipilimumab (11) 11
ligands (11) 11
lung neoplasms - pathology (11) 11
melanoma - genetics (11) 11
mutation (11) 11
pd-1 blockade (11) 11
programmed cell death 1 receptor - metabolism (11) 11
t cells (11) 11
therapy (11) 11
tumor microenvironment - immunology (11) 11
anti-pd-1 (10) 10
antineoplastic agents - therapeutic use (10) 10
b7-h1 antigen - genetics (10) 10
biopsy (10) 10
chemotherapy (10) 10
diagnosis, differential (10) 10
gene expression (10) 10
immune response (10) 10
medicine, research & experimental (10) 10
melanoma - immunology (10) 10
mice (10) 10
prognosis (10) 10
programmed cell death 1 receptor - immunology (10) 10
skin neoplasms - metabolism (10) 10
antibodies, monoclonal - therapeutic use (9) 9
carcinoma, non-small-cell lung - drug therapy (9) 9
carcinoma, non-small-cell lung - pathology (9) 9
cell line, tumor (9) 9
cells (9) 9
melanoma - drug therapy (9) 9
melanoma - metabolism (9) 9
pembrolizumab (9) 9
skin neoplasms - diagnosis (9) 9
tumor microenvironment (9) 9
young adult (9) 9
breast cancer (8) 8
lung cancer (8) 8
medicine, general & internal (8) 8
melanoma - diagnosis (8) 8
metastases (8) 8
neoplasms - immunology (8) 8
skin neoplasms - genetics (8) 8
solid tumors (8) 8
t-cells (8) 8
tumor-infiltrating lymphocytes (8) 8
antibodies (7) 7
antibodies, monoclonal - adverse effects (7) 7
antibody (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Human pathology, ISSN 0046-8177, 2016, Volume 47, Issue 1, pp. 52 - 63
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2016, Volume 374, Issue 26, pp. 2542 - 2552
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2015, Volume 372, Issue 26, pp. 2509 - 2520
Persons with mismatch repair–deficient tumors are more likely than persons with mismatch repair–proficient tumors to benefit from pembrolizumab — which... 
MEDICINE, GENERAL & INTERNAL | COLORECTAL CARCINOMAS | ANTI-PD-L1 ANTIBODY | SAFETY | MICROSATELLITE INSTABILITY | DNA | GERMLINE MUTATIONS | PREDISPOSE | CLINICAL ACTIVITY | CANCER | LYMPHOCYTES | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Colorectal Neoplasms - genetics | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Disease-Free Survival | Neoplasm Metastasis - genetics | Neoplasm Metastasis - drug therapy | Antineoplastic Agents - adverse effects | Colorectal Neoplasms - drug therapy | DNA Mismatch Repair | Adult | Female | Adenocarcinoma - genetics | Aged | Colorectal Neoplasms - pathology | Antibody diversity | Carcinoma | Genetic disorders | Analysis | Research | Risk factors | Cancer | Tumors | Antigens | Yeast | PD-1 protein | Colorectal carcinoma | Body weight | Colorectal cancer | Autoantigens | DNA repair | Survival | Metastases | Pembrolizumab | Immune checkpoint | Immunogenicity | Mismatch repair | Death | Mutation | Genetic recombination | Cancer therapies | Drug dosages | Immune system | Medical research | Melanoma | Patients | Studies | Hypotheses | Pancreatic cancer | Epigenetics | Biomarkers | Ligands
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 378, Issue 21, pp. 1976 - 1986
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2016, Volume 375, Issue 18, pp. 1749 - 1755
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2012, Volume 366, Issue 26, pp. 2443 - 2454
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2010, Volume 28, Issue 19, pp. 3167 - 3175
Journal Article